Secernin-1 as a marker for cancer

Details Secernin-1 as a marker for cancer Secernin-1 as a marker for cancer

G - Physics

01

N

G01N 33/574 (2006.01)

Patent

CA 2760366

The present invention relates to a method aiding in the assessment of cancer. It discloses the use of the Secemin-1 protein (= SCRN1) as a universal marker of different cancer types. Furthermore, it especially relates to a method for assessing cancer from a liquid sample, derived from an individual by measuring SCRN1 in said sample. Measurement of SCRN1 can, e.g., be used in the early detection of cancer or in the surveillance of patients who undergo surgery.

La présente invention porte sur un procédé qui aide à l'évaluation du cancer. Elle décrit l'utilisation de la protéine sémécine-1 (SCRN1) en tant que marqueur universel de différents types de cancer. Elle porte en outre sur un procédé d'évaluation d'un cancer à partir d'un échantillon liquide, obtenu d'un individu, par mesure du SCRN1 dans ledit échantillon. On peut utiliser par exemple la mesure du SCRN1 au cours de la détection précoce d'un cancer, ou pour la surveillance de patients subissant une intervention chirurgicale.

Affiliated with

Also associated with

Rating

Secernin-1 as a marker for cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Secernin-1 as a marker for cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Secernin-1 as a marker for cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1737160